Suppr超能文献

β3 -肾上腺素能受体激动剂BRL 35135在麻醉大鼠棕色脂肪组织产热及血流量增加方面的异质性活性。

Heterogenous activity of BRL 35135, a beta 3-adrenoceptor agonist, in thermogenesis and increased blood flow in brown adipose tissue in anaesthetized rats.

作者信息

Takahashi H, Nakamura S, Shirahase H, Yoshida T, Nishimura M, Yoshimura M

机构信息

Department of Clinical Sciences, Kansai Medical University, Moriguchi, Japan.

出版信息

Clin Exp Pharmacol Physiol. 1994 Jul;21(7):539-43. doi: 10.1111/j.1440-1681.1994.tb02553.x.

Abstract
  1. The effects of BRL 35135, a beta 3-adrenergic agonist, on body temperature and regional blood flow in brown adipose tissue (BAT) were simultaneously recorded in anaesthetized rats and compared to isoproterenol. 2. BRL 35135 at doses of 0.1 and 1 micrograms/kg (i.v.) induced dose-dependent increases in BAT temperature with minimal effects on systemic diastolic blood pressure (DBP), heart rate (HR) and BAT blood flow. 3. The thermogenic effect of BRL 35135 at a dose of 10 micrograms/kg (i.v.) was smaller than that at a dose of 1 microgram/kg, and was accompanied by a marked increase in BAT blood flow. 4. Isoproterenol at doses of 0.01-1 microgram/kg (i.v.) dose-dependently increased HR and BAT blood flow and decreased DBP. It did not affect BAT temperature. 5. These findings indicate that unlike isoproterenol, BRL 35135, at the lower doses, selectively causes thermogenesis in BAT which was detectable as changes in BAT temperature, and that the vasodilator effect in BAT is not as sensitive as the thermogenic effect of beta 3-adrenergic agonists.
摘要
  1. 在麻醉大鼠中同时记录β3-肾上腺素能激动剂BRL 35135对体温及棕色脂肪组织(BAT)局部血流的影响,并与异丙肾上腺素作比较。2. 静脉注射剂量为0.1和1微克/千克的BRL 35135可使BAT温度呈剂量依赖性升高,而对全身舒张压(DBP)、心率(HR)及BAT血流影响极小。3. 静脉注射剂量为10微克/千克的BRL 35135的产热效应小于1微克/千克剂量时的效应,且伴有BAT血流显著增加。4. 静脉注射剂量为0.01 - 1微克/千克的异丙肾上腺素可使HR和BAT血流呈剂量依赖性增加,使DBP降低。它对BAT温度无影响。5. 这些发现表明,与异丙肾上腺素不同,较低剂量的BRL 35135可选择性地引起BAT产热,这可通过BAT温度变化检测到,且BAT中的血管舒张效应不如β3-肾上腺素能激动剂的产热效应敏感。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验